Senseonics Holdings, Inc. (SENS): Price and Financial Metrics
GET POWR RATINGS... FREE!
SENS POWR Grades
- Growth is the dimension where SENS ranks best; there it ranks ahead of 62.87% of US stocks.
- SENS's strongest trending metric is Value; it's been moving up over the last 179 days.
- SENS's current lowest rank is in the Stability metric (where it is better than 0.84% of US stocks).
SENS Stock Summary
- With a price/sales ratio of 67.06, Senseonics Holdings Inc has a higher such ratio than 96.9% of stocks in our set.
- SENS's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of only 4.84% of US stocks.
- Revenue growth over the past 12 months for Senseonics Holdings Inc comes in at 176.32%, a number that bests 95.3% of the US stocks we're tracking.
- If you're looking for stocks that are quantitatively similar to Senseonics Holdings Inc, a group of peers worth examining would be CLSN, NVCN, ABEO, SMTC, and BLI.
- Visit SENS's SEC page to see the company's official filings. To visit the company's web site, go to www.senseonics.com.
SENS Valuation Summary
- In comparison to the median Healthcare stock, SENS's price/earnings ratio is 108.77% lower, now standing at -3.2.
- Over the past 69 months, SENS's price/sales ratio has gone down 6313.4.
- SENS's price/sales ratio has moved down 6313.4 over the prior 69 months.
Below are key valuation metrics over time for SENS.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| SENS | 2021-08-31 | 165.5 | -5.7 | -3.2 | -3.3 |
| SENS | 2021-08-30 | 157.3 | -5.4 | -3.1 | -3.1 |
| SENS | 2021-08-27 | 167.2 | -5.8 | -3.2 | -3.3 |
| SENS | 2021-08-26 | 160.2 | -5.5 | -3.1 | -3.2 |
| SENS | 2021-08-25 | 153.5 | -5.3 | -3.0 | -3.1 |
| SENS | 2021-08-24 | 151.1 | -5.2 | -2.9 | -3.0 |
SENS's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- SENS has a Quality Grade of D, ranking ahead of 13.13% of graded US stocks.
- SENS's asset turnover comes in at 0.084 -- ranking 71st of 76 Measuring and Control Equipment stocks.
- A, ASTC, and MTD are the stocks whose asset turnover ratios are most correlated with SENS.
The table below shows SENS's key quality metrics over time.
| Period | Asset Turnover | Gross Margin | ROIC |
|---|---|---|---|
| 2021-06-30 | 0.084 | 0.401 | -5.465 |
| 2021-03-31 | 0.098 | 0.360 | -5.709 |
| 2020-12-31 | 0.127 | -3.509 | -2.449 |
| 2020-09-30 | 0.158 | -2.814 | -1.660 |
| 2020-06-30 | 0.144 | -2.385 | -1.365 |
| 2020-03-31 | 0.165 | -1.997 | -1.885 |
SENS Stock Price Chart Interactive Chart >
SENS Price/Volume Stats
| Current price | $1.13 | 52-week high | $4.58 |
| Prev. close | $1.12 | 52-week low | $0.77 |
| Day low | $1.10 | Volume | 2,918,759 |
| Day high | $1.16 | Avg. volume | 10,089,365 |
| 50-day MA | $1.55 | Dividend yield | N/A |
| 200-day MA | $2.67 | Market Cap | 523.49M |
Senseonics Holdings, Inc. (SENS) Company Bio
Senseonics Holdings, Inc. focuses on the design, development, and commercialization of glucose monitoring systems for people with diabetes. The company was founded in 1996 and is based in Germantown, Maryland.
Latest SENS News From Around the Web
Below are the latest news stories about Senseonics Holdings Inc that investors may wish to consider to help them evaluate SENS as an investment opportunity.
Senseonics Holdings (SENS) Gets a Hold Rating from BTIGIn a report released today, Marie Thibault from BTIG reiterated a Hold rating on Senseonics Holdings (SENS – Research Report). The company's shares closed last Wednesday at $1.83, close to its 52-week low of $1.40. According to TipRanks.com, Thibault is a 5-star analyst with an average return of 22.6% and a 38.7% success rate. Thibault covers the Healthcare sector, focusing on stocks such as Establishment Labs Holdings, Edwards Lifesciences, and Irhythm Technologies. The word on The Street in general, suggests a Hold analyst consensus rating for Senseonics Holdings with a $1.90 average price target. |
Analysts’ Opinions Are Mixed on These Technology Stocks: Avid Technology (AVID), Lattice Semiconductor (LSCC) and Senseonics Holdings (SENS)Companies in the Technology sector have received a lot of coverage today as analysts weigh in on Avid Technology (AVID – Research Report), Lattice Semiconductor (LSCC – Research Report) and Senseonics Holdings (SENS – Research Report). Avid Technology (AVID) In a report released today, Steve Frankel from Colliers Securities maintained a Hold rating on Avid Technology. The company's shares closed last Tuesday at $29.00. According to TipRanks.com, Frankel is a 2-star analyst with an average return of -5.5% and a 36.2% success rate. Bauser covers the Healthcare sector, focusing on stocks such as Apollo Medical Holdings, Chembio Diagnostics, and Semler Scientific. |
Senseonics ticks up on Q4 earnings beatSenseonics (NYSE:SENS) shares ticked up today on fourth-quarter results that came in ahead of the consensus forecast. The Germantown, Maryland-based company posted revenues of $4 million for the three months ended Dec. 31, 2021, representing sales growth of 2.6% from the same period in 2020. Adjusted to exclude one-time items, earnings per share were 1¢, […] The post Senseonics ticks up on Q4 earnings beat appeared first on Drug Delivery Business . |
Senseonics Holdings (SENS) Beats Q4 Earnings and Revenue EstimatesSenseonics (SENS) delivered earnings and revenue surprises of 133.33% and 0.20%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock? |
Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2021 Financial ResultsGERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today reported financial results for the quarter and full year ended December 31, 2021. Recent Highlights & Accomplishments: Received approval from the Food and Drug Administration (FDA) for the Eversense® E3 CGM System, offering patients: Fu |
SENS Price Returns
| 1-mo | -25.17% |
| 3-mo | -38.92% |
| 6-mo | -65.02% |
| 1-year | -42.64% |
| 3-year | -44.06% |
| 5-year | -31.93% |
| YTD | -57.68% |
| 2021 | 206.26% |
| 2020 | -4.83% |
| 2019 | -64.63% |
| 2018 | -2.63% |
| 2017 | -0.37% |
Continue Researching SENS
Want to do more research on Senseonics Holdings Inc's stock and its price? Try the links below:Senseonics Holdings Inc (SENS) Stock Price | Nasdaq
Senseonics Holdings Inc (SENS) Stock Quote, History and News - Yahoo Finance
Senseonics Holdings Inc (SENS) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...